Chicago Partners Investment Group’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,278
Closed -$396K 1514
2025
Q4
$396K Buy
5,278
+1,002
+23% +$73.2K 0.01% 895
2025
Q3
$316K Buy
+4,276
New +$284K 0.01% 913
2018
Q4
Sell
-200
Closed -$8K 584
2018
Q3
$8K Hold
200
﹤0.01% 857
2018
Q2
$8K Hold
200
﹤0.01% 837
2018
Q1
$7K Hold
200
﹤0.01% 815
2017
Q4
$9K Hold
200
﹤0.01% 763
2017
Q3
$7K Sell
200
-200
-50% -$8.07K ﹤0.01% 823
2017
Q2
$17K Buy
+400
New +$17.7K ﹤0.01% 528

Other funds holding HOLX

Chicago Partners Investment Group's HOLX Position: Q1 2026 in Review

Chicago Partners Investment Group sold out of Hologic (HOLX) in Q1 2026, closing a stake of 5,278 shares — an estimated $396K sold.

Chicago Partners Investment Group first reported a position in HOLX in Q2 2017 and held it in 8 quarters. The position peaked at $396K in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Chicago Partners Investment Group reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Chicago Partners Investment Group sold 5,278 Hologic shares in Q1 2026, an estimated $396K.
  • Chicago Partners Investment Group first reported a position in Hologic in Q2 2017 and held it in 8 quarters.
  • Chicago Partners Investment Group's Hologic position peaked at $396K in Q4 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.